Neville Rodie & Shaw Inc / MRK
Neville Rodie & Shaw Inc’s Merck & Co Inc Position
Does Neville Rodie & Shaw Inc own Merck & Co Inc (MRK)? Yes — 87.7K shares worth $11M (+0.73% of its 13F portfolio) as of Q2 2026, down from 87.8K shares the prior filed quarter.
Position Value
$11M
Q2 2026
Shares
87.7K
% of Portfolio
+0.73%
Quarters Held
30
currently held
Position History MRK
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2026 | 87.7K | $11M | +0.73% |
| Q1 2026 | 87.8K | $11M | +0.77% |
| Q4 2025 | 87.8K | $9M | +0.65% |
| Q3 2025 | 123.0K | $10M | +0.75% |
| Q2 2025 | 142.6K | $11M | +0.84% |
| Q1 2025 | 167.2K | $15M | +1.18% |
| Q4 2024 | 177.4K | $18M | +1.29% |
| Q3 2024 | 176.0K | $20M | +1.47% |
| Q2 2024 | 183.0K | $23M | +1.72% |
| Q1 2024 | 184.8K | $24M | +1.86% |
| Q4 2023 | 185.6K | $20M | +1.65% |
| Q3 2023 | 188.0K | $19M | +1.73% |
| Q2 2023 | 188.3K | $22M | +1.87% |
| Q1 2023 | 193.0K | $21M | +1.86% |
| Q4 2022 | 193.6K | $21M | +2.02% |
| Q3 2022 | 190.3K | $16M | +1.61% |
| Q2 2022 | 194.2K | $18M | +1.59% |
| Q1 2022 | 199.9K | $17M | +1.24% |
| Q4 2021 | 201.4K | $15M | +1.09% |
| Q3 2021 | 202.6K | $15M | +1.18% |
| Q2 2021 | 229.1K | $18M | +1.37% |
| Q1 2021 | 240.3K | $19M | +1.53% |
| Q3 2020 | 253.3K | $21M | +1.98% |
| Q2 2020 | 254.7K | $20M | +2.03% |
| Q1 2020 | 255.4K | $20M | +2.39% |
| Q4 2019 | 255.7K | $23M | +2.28% |
| Q3 2019 | 256.8K | $22M | +2.29% |
| Q2 2019 | 262.3K | $22M | +2.33% |
| Q1 2019 | 266.9K | $22M | +2.35% |
| Q4 2018 | 271.6K | $21M | +2.52% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Neville Rodie & Shaw Inc’s full portfolio or all institutional holders of MRK.